|

SGLT-2 inhibitors Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 2: 2

Top Sponsors

  • Minneapolis Heart Institute Foundation1
  • Huashan Hospital1

Indications

  • Heart Disease2
  • Enlarged Heart1
  • Atrial Fibrillation (AF)1
  • Heart Attack1
  • Hypertension1

Other1 trial

SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism
Phase 2

Minneapolis, Minnesota1 trial

Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

Minneapolis Heart Institute Foundation

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.